Article Details
Retrieved on: 2018-02-18 17:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Roche is finishing the job and buying out the rest of <b>Flatiron Health</b> for $1.9B, making their total investment in the company close to $2.1B (they owned 13% of the biotech company before the deal). Roche also led Flatiron's last round of funding, valuing the company at $1.1B, with Roche's cancer drugs ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here